Health Care & Life Sciences » Biotechnology | Shanghai Hile Bio-Technology Co. Ltd.

Shanghai Hile Bio-Technology Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
315,921.00
341,504.50
301,728.60
252,045.30
Cost of Goods Sold (COGS) incl. D&A
-
76,649.00
113,108.00
93,036.80
126,812.30
Gross Income
-
239,272.10
228,396.50
208,691.80
125,233
SG&A Expense
-
141,295.90
162,241.00
143,991.90
133,591.40
EBIT
-
97,976.10
66,205.50
64,699.90
8,860.10
Unusual Expense
-
-
-
2,500.00
-
Non Operating Income/Expense
-
3,048.50
94.70
27,695.00
11,763.90
Interest Expense
-
152.30
5,995.70
11,855.20
14,956.20
Pretax Income
-
108,343.90
76,894.30
103,685.80
5,790.70
Income Tax
-
17,010.40
6,848.60
11,828.30
12,480
Equity in Affiliates
-
-
-
3,437.00
4,562.90
Consolidated Net Income
-
91,333.50
70,045.70
95,294.50
13,707.80
Net Income
-
95,402.60
85,536.40
113,739.50
21,298.20
Net Income After Extraordinaries
-
95,402.60
85,536.40
113,739.50
21,298.20
Net Income Available to Common
-
95,402.60
85,536.40
113,739.50
21,298.20
EPS (Basic)
-
0.17
0.13
0.18
0.03
Basic Shares Outstanding
-
577,436.90
644,000.00
644,000.00
644,000
EPS (Diluted)
-
0.17
0.13
0.18
0.03
Diluted Shares Outstanding
-
577,436.90
644,000.00
644,000.00
644,000
EBITDA
-
127,798.80
115,316.00
122,831.70
52,848.80
Other Operating Expense
-
-
50.00
-
501.70
Non-Operating Interest Income
-
12,135.70
15,179.20
20,646.10
29,789.50
Minority Interest Expense
-
4,069.10
15,490.70
18,445.00
35,006

About Shanghai Hile Bio-Technology Co.

View Profile
Address
No. 6720 Jinhai Road
Shanghai Shanghai 201403
China
Employees -
Website http://www.hile-bio.com
Updated 07/08/2019
Shanghai Hile Bio-Technology Co., Ltd. engages in the manufacture and sale of veterinary vaccine and inactivated vaccine. It specializes in pig, poultry, and pet vaccine products. It offers inactivated rabies vaccines, avian infectious bronchitis vaccine, swine fever vaccine, porcine transmissible gastroenteritis and porcine epidemic diarrhea bivalent inactivated vaccine, highly pathogenic blue ear pig disease vaccine, porcine reproductive and respiratory syndrome vaccine, and porcine circovirus type 2 inactivated vaccine.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.